
"Sector" = median of Basic Materials across 63 companies
International Flavors & Fragrances Inc. (IFF) is a leading global creator of flavors, fragrances, and cosmetic actives. The company produces specialty ingredients used in food, beverages, personal care, and household products. IFF operates through four segments: Nourish (taste and texture solutions), Health & Biosciences (enzymes, probiotics, and food protection), Scent (fine fragrances and consumer scents), and Pharma Solutions (excipients and drug delivery). Its products enhance taste, smell, and functionality in consumer goods.
IFF generates revenue primarily from selling ingredient solutions to manufacturers. The business model is B2B, with long-term contracts and co-innovation partnerships. Revenue is diversified across segments: Nourish contributes about 35%, Scent around 30%, Health & Biosciences 25%, and Pharma Solutions 10%. The company focuses on high-margin, value-added products, with gross margins of 36% and operating margins near 8%. Recent trends show declining revenue (-3.6% YoY) but a sharp earnings recovery (+117% YoY) due to cost restructuring.
IFF competes in the specialty chemicals industry, a fragmented market with key rivals like Givaudan, Firmenich, and Symrise. The sector is driven by consumer trends toward natural ingredients, sustainability, and health & wellness. IFF positions itself as a science-led innovator with a broad portfolio spanning food, health, and scent. Its scale (market cap ~$19B) and R&D investment provide competitive advantages, though high debt ($5.8B) and cyclical demand pose risks.
IFF serves a diverse customer base including global food & beverage companies (e.g., Nestlé, PepsiCo), personal care brands (e.g., L'Oréal, Unilever), and pharmaceutical firms. Geographically, revenue is split roughly 40% North America, 30% Europe/Middle East/Africa, 20% Asia Pacific, and 10% Latin America. The company has a strong presence in emerging markets, particularly for flavors and biosciences.
An auto-generated descriptive profile based on company data, for informational purposes only.
No 24-hour summary has been generated yet.
Latest saved period: March 2026 · 2026-03-31
Cash dividends by ex-date, not an investment recommendation.
| Ex-date | Amount | Payment date | Period |
|---|---|---|---|
| Mar 20, 2026 | $0.40 | Apr 10, 2026 | Quarterly |
| Dec 19, 2025 | $0.40 | Jan 9, 2026 | Quarterly |
| Sep 29, 2025 | $0.40 | Oct 10, 2025 | Quarterly |
| Jun 20, 2025 | $0.40 | Jul 11, 2025 | Quarterly |
| Mar 21, 2025 | $0.40 | Apr 11, 2025 | Quarterly |
| Dec 20, 2024 | $0.40 | Jan 8, 2025 | Quarterly |
| Sep 20, 2024 | $0.40 | Oct 9, 2024 | Quarterly |
| Jun 21, 2024 | $0.40 | Jul 10, 2024 | Quarterly |
| Mar 21, 2024 | $0.40 | Apr 10, 2024 | Quarterly |
| Dec 27, 2023 | $0.81 | Jan 8, 2024 | Quarterly |
| Sep 21, 2023 | $0.81 | Oct 5, 2023 | Quarterly |
| Jun 22, 2023 | $0.81 | Jul 11, 2023 | Quarterly |
| Mar 23, 2023 | $0.81 | Apr 6, 2023 | Quarterly |
| Dec 27, 2022 | $0.81 | Jan 6, 2023 | Quarterly |
| Sep 22, 2022 | $0.81 | Oct 5, 2022 | Quarterly |
| Jun 23, 2022 | $0.79 | Jul 6, 2022 | Quarterly |
| Mar 24, 2022 | $0.79 | Apr 6, 2022 | Quarterly |
| Dec 27, 2021 | $0.79 | Jan 7, 2022 | Quarterly |
| Sep 23, 2021 | $0.79 | Oct 5, 2021 | Quarterly |
| Jun 24, 2021 | $0.77 | Jul 6, 2021 | Quarterly |
| Mar 25, 2021 | $0.77 | Apr 6, 2021 | Quarterly |
| Dec 24, 2020 | $0.77 | Jan 7, 2021 | Quarterly |
| Sep 23, 2020 | $0.77 | Oct 5, 2020 | Quarterly |
| Jun 24, 2020 | $0.75 | Jul 6, 2020 | Quarterly |
Wrqti brings International Flavors & Fragran data into one page covering available price, financial statements, valuation ratios, margins, cash-flow metrics, news, and alerts. This page helps you understand the numbers and is not a buy or sell recommendation.
Companies in the Basic Materials sector you can compare with International Flavors & Fragran:
When available, the page shows quarterly and annual statements plus ratios such as PE, price to book, profit margin, and free cash flow. Latest financial period shown: March 2026.
Wrqti content depends on available data and third-party sources and may include delays or errors. Review official company filings and consult a licensed financial advisor before making investment decisions. Read the data methodology.